Skip to main content
. 2020 Jul 10;10:1108. doi: 10.3389/fonc.2020.01108

Figure 2.

Figure 2

MNX1-AS1 promotes progression of TNBC in vitro. (A) MNX1-AS1 mainly expressed in cytoplasm in MDA-MB-231, as indicated by Immunofluorescence. (B) Silencing efficacy of siRNAs (si-1 and si-2) to MNX1-AS1 were over 50% in MDA-MB-231. MNX1-AS1 expression was determined using qRT-PCR and normalized to siCTL expression. Bar graphs represent the mean ± SD of experimental triplicates. (C) Silencing MNX1-AS1 reduced viability of MDA-MB-231, as detected by MTS assay. Bar graphs represent the mean ± SD of experimental triplicates. (D) Silencing MNX1-AS1 reduced colony formation of MDA-MB-231. (E,F) Silencing MNX1-AS1 reduced migration and invasion of MDA-MB-231 cells. Culture inserts were coated with or without matrigel for the Boyden chamber assay of MDA-MB-231. (G) Silencing MNX1-AS1 induced apoptosis of MDA-MB231 cells. **P < 0.01 and ***P < 0.001.